loader

nasdaq:tenx

LATEST ARTICLES
Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 for the Treatment of PH-HFpEF

Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 for the Treatment of PH-HFpEF

Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF

Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025

Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025

Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Tenax Therapeutics Inc.

Tenax Therapeutics Inc.

5 Top Pharmaceutical News Stories of 2019
pharmaceutical-investing

5 Top Pharmaceutical News Stories of 2019

pharmaceutical-investing

Tenax Therapeutics Updates on Phase 2 Pulmonary Trial

Video Round-Up: Biotech Showcase Conference 2019

Video Round-Up: Biotech Showcase Conference 2019

Tenax Therapeutics Working on Phase 2 Trial
pharmaceutical-investing

Tenax Therapeutics Working on Phase 2 Trial

Notes from the Floor: Biotech Showcase, Day 1

Tenax Therapeutics Activates First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES